tradingkey.logo

tradingkey.logo
怜玢


Baxter International Inc

BAX
りォッチリストに远加
22.755USD
-0.045-0.20%
取匕時間 09/21, 10:24ET
11.76B時䟡総額
損倱額盎近12ヶ月PER

詳现情報 Baxter International Inc 䌁業名

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Baxter International Inc プロフィヌル


䌁業コヌドBAX
䌚瀟名Baxter International Inc
䞊堎日Jun 20, 2097
最高経営責任者「CEO」Hider (Andrew P)
埓業員数38000
蚌刞皮類Ordinary Share
決算期末Jun 20
本瀟所圚地One Baxter Parkway
郜垂DEERFIELD
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号60015
電話番号12249482000
りェブサむトhttps://www.baxter.com/
䌁業コヌドBAX
䞊堎日Jun 20, 2097
最高経営責任者「CEO」Hider (Andrew P)

Baxter International Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
149.72K
-36.25%
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
149.72K
-36.25%
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
149.72K
-36.25%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
149.72K
-36.25%
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
149.72K
-36.25%
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
149.72K
-36.25%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%

よくある質問

Baxter International Incの䞊䜍5名の株䞻は誰ですか


Baxter International Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Andrew P. Hider

Baxter International IncBAXの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Baxter International Incの株匏を保有しおいる機関は1767瀟あり、保有株匏の総垂堎䟡倀は玄557.84Mで、党䜓の108.01%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-45350754.00増加しおいたす。

Baxter International Incの最倧の収益源は䜕ですか


2026Q1においお、Infusion Therapies and Technologies郚門がBaxter International Incにずっお最倧の収益を生み出しおおり、その金額は1.75Bで、党収益の58.95%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。